Sandra Shpilberg is the Founder and President of Seeker Health. She founded Seeker Health to harness the power of technology to connect patients to clinical trials and help the biopharmaceutical industry accelerate drug development and innovation. Prior to founding Seeker Health, Sandra was an executive at Nora Therapeutics and at BioMarin Pharmaceutical, where she led commercial launches and product development for treatments for rare diseases. In 2018, EVERSANA acquired Seeker Health. She graduated with a BBA from Pace University and an MBA from The Wharton School at the University of Pennsylvania. Medical Marketing & Media named her at Top 40 Healthcare Transformer and she was a featured speaker at 2018 SXSW.
Paul Ivsin has more than 15 years of leadership experience in pharmaceutical clinical trial recruitment, patient engagement, and analytics. Most recently he was an independent consultant for medical advertising agencies, including PEP. Previously, he served as the Director of Offerings Development at IMS Health, a global information and technology services company, where he led new product development for clinical trial recruitment as well as feasibility data products and services. Prior to that, he led the Clinical Trial Recruitment practice at CAHG, a leading medical advertising agency. Earlier in his career, Paul cofounded CMJ Solutions, a company that provided online database solutions for clinical trial enrollment tracking and campaign performance measurement. Ivsin is the author of several articles and blogs about clinical trials. His work has been published in Applied Clinical Trials, Clinical Informatics News, and Eye for Pharma.
Sharon Francis is a seasoned digital marketer with over 10 years of experience in online ad and website design, project and financial management. Sharon previously served as Director of Program Management at Carat and Associate Director at DigitasLBi, where she produced award-winning advertising campaigns. Sharon started her career at Deloitte Consulting as a healthcare consultant. She earned a BA from Barnard College. Sharon has a passion for the growing use of social media and its potential to revolutionize clinical trials.
Emily Cortez brings over 18 years in the healthcare industry, with most of her career focused on clinical trial recruitment. She started her career at a clinical trial site where she oversaw patient recruitment efforts, interacting with patients, nurses, physicians and sponsors, sparking her passion for working in the healthcare industry. She shifted from support at the site-level to overseeing large-scale campaigns in an account management role, where she has worked with her team to follow the trends to develop innovative solutions in the ever-changing recruitment landscape.
Nadia Espinoza studied communications with an emphasis in media at University of California, San Diego. Post academics, Nadia returned home to the San Francisco Bay Area, and proceeded to work in a fast, dynamic environment, assuring hands-on experience on startup ground. Passionate about technology, Nadia has since continued to pursue professional development in tech-based startups. Her background includes roles in marketing, media, and operations.
Becca Triplett manages and analyzes our clinical trial enrollment campaigns including the deployment of Facebook and Google media, setting up clinical trial websites and administering Seeker Portal assistance to sites. Becca is passionate about innovative health solutions and is excited to be a part of a company that impacts so many lives. Becca earned her B.S. degree in Human Biology at Stanford University. During her time at Stanford, she gained insight to the clinical trial process at both the Stanford Medical Center as well as Massachusetts General Hospital in Boston. In her free time she loves to hike, scuba dive, and read.
Amy Ye is a graphic designer who helps develop digital assets for campaigns and websites, as well as marketing collateral for Seeker Health. She is currently pursuing a double major in Design and Managerial Economics at UC Davis.
AnneMarie Schmidt is a Registered Nurse and works as a case manager for Seeker Health. In this position, AnneMarie continues the pre-screening process, helping to accelerate enrollment of clinical studies for new medicines for serious disease. Previously, AnneMarie worked in various nursing capacities, including oncology, perioperative, geriatric, community-based, as well as emergency disaster relief work. In addition, AnneMarie’s experience as a nursing home administrator, hospice clinical director, as well as her work in the biotech industry has also provided a broad background in the healthcare field. AnneMarie graduated with a BS in Biology from Westmont College as well as a BSN and MBA from Northern Arizona University.
Board of Advisors
Barbara K. Burton, MD, is a Professor of Pediatrics at the Northwestern University Feinberg School of Medicine and Clinical Practice Director and Director of the Phenylketonuria (PKU) Treatment Program in the Division of Genetics, Birth Defects and Metabolism at the Ann & Robert H. Lurie Children’s Hospital of Chicago. Her major clinical and research interests are in the area of inborn errors of metabolism. She is Board Certified in Pediatrics, Clinical Genetics and Clinical Biochemical Genetics. She is the past President of the Chicago Pediatric Society, and past President of the Society for Inherited Metabolic Disorders. She is a member of the Genetic and Metabolic Advisory Committee to the Illinois Department of Public Health and is Chairman of the Lysosomal Storage Disorders Subcommittee. She has contributed over 200 articles and chapters to medical literature, many of them focusing on the diagnosis and treatment of inborn errors of metabolism and on the prenatal diagnosis of genetic disorders.
Dan Oppenheimer, Ph.D. is Chief Operating Officer at Reset Therapeutics, a biotechnology company developing therapeutics for diseases linked to dysfunctional circadian rhythms. Previously, Dan was Group Vice President, Development and Portfolio Strategy at BioMarin Pharmaceutical, with responsibility for pipeline product development, product strategy, and portfolio planning. He previously served in several roles in Business Development and Product Development at BioMarin. During his fourteen years at BioMarin, Dan was involved in the development and approval of four therapeutics, as well as several other preclinical and clinical stage programs currently in development. Prior to joining BioMarin, Dan was a consultant at McKinsey and Company in San Francisco, advising biotechnology companies. He earned a Ph.D. in Entomology from the University of California, Berkeley, an M.B.A. at the University of Chicago Graduate School of Business and a B.A. in Molecular Biology and Biochemistry from Wesleyan University.
Luke Gelinas is a Fellow in Research Ethics at the Petrie-Flom Center for Health Law Policy, Biotechnology and Bioethics at Harvard Law School. Luke earned his PhD in 2014 from the University of Toronto, where he was a graduate fellow at the University of Toronto’s Centre for Ethics; he also has an MA in Religion summa cum laude from Yale Divinity School. Most recently, Luke completed a Postdoctoral Fellowship in Bioethics at the National Institutes of Health and training in Clinical Ethics at Albany Medical College. Luke’s research interests focus primarily on the concept of informed consent. Currently, his work advances several projects as part of the Harvard Catalyst Regulatory Foundations, Ethics, and Law Program, with a particular emphasis on the regulatory, ethical, and practical aspects associated with recruitment and retention of research participants.
Kendra Gottsleben is a Marketing Communication Specialist, author, and spokesperson on living a life with a rare disease and disability. Her career blends the two worlds in which she grew up: medicine and education. Kendra provides support to families and children who have severe or life-threatening illnesses or disabilities. She has defined her life by a positive outlook and success in overcoming obstacles, and refuses to be defined by MPS — the rare genetic condition she has had since birth. Watch her inspirational TED talk, "When Life Gives You Lemons."